Overview

Study In Postmenopausal Women With Type 2 Diabetes Looking At Approved Diabetes Drugs And How They Affect Bone Health

Status:
Completed
Trial end date:
2010-09-16
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effects of rosiglitazone on the bone in postmenopausal women with type 2 diabetes mellitus
Phase:
Phase 4
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Metformin
Rosiglitazone